相关实验视频

Updated: Jan 9, 2026

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

在传统医疗保险受益者中描述吉兰-巴雷风险因素

Brad Wright¹, Samantha R Eiffert², Abagail Cirincione¹

¹Arnold School of Public Health, University of South Carolina, Columbia, USA.

Inquiry : a journal of medical care organization, provision and financing

|December 4, 2025

概括

吉兰-巴雷综合征 (GBS) 与脂质代谢障碍和认知障碍有关. 医疗保险-医疗补助双重资格和残疾状况也与GBS发病相关,这表明社会经济因素起着作用.

科学领域:

神经学神经学
流行病学流行病学
自身免疫性疾病自身免疫性疾病

背景情况:

吉兰-巴雷综合征 (GBS) 是一种罕见的,严重的自身免疫性疾病,影响周围神经.
了解与GBS发病相关的人口和临床因素对于早期识别和管理至关重要.
以前的研究强调感染是触发因素,但其他并发症和社会经济因素的作用需要进一步调查.

研究的目的:

确定与吉兰-巴雷综合征 (GBS) 发病相关的人口和临床特征.
调查先前和先前的临床条件与GBS发病率之间的关联.
通过使用大规模索赔数据,探索社会经济和残疾状况对GBS发生的影响.

主要方法:

使用2005-2020年医疗保险服务费索赔数据进行的回顾性病例控制研究.
通过使用经过验证的算法识别了16,280例GBS事件,与对照对应1:1.
使用修改后的波桑回归来分析GBS发病与临床条件 (先前存在和先前在42天内出现) 之间的关联,调整以人口和社会经济变量为准.

主要成果:

以前存在的脂质代谢障碍 (aOR≈1.04) 和肠道感染 (aOR≈1.05) 与GBS有关.
与GBS相关的先前疾病包括脂质代谢障碍 (aOR≈1.05),认知障碍 (aOR≈1.14) 和慢性皮肤 (aOR≈1.07).
在这两种模型中,GBS显示了与Medicare-Medicaid双重资格和残疾身份的积极关联.

结论:

研究结果表明,GBS与代谢,感染和认知条件之间存在潜在联系,这需要进一步的机制研究.
与双重资格和残疾身份的关联凸显了社会经济和结构因素在总体支付系统中的潜在作用.
医疗保险索赔数据可以成为研究GBS等罕见疾病流行病学的宝贵工具.

关键词:

吉兰 - 巴雷综合征是什么?美国医疗保险 (Medicare) 的医疗保险.大数据就是大数据.神经病变是一种神经病变.罕见疾病是一种罕见的疾病.

更多相关视频

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

相关概念视频

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

Factors Affecting the Risk of Infection

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Factors Affecting Illness

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...